Use of an anagrelide, anagrelide in base form, or a pharmaceutically acceptable salt of anagrelide, non-oral pharmaceutical composition, and transdermal delivery device

摘要

"USE OF ANAGRELIDE, ANAGRELIDE IN BASE FORM, OR PHARMACEUTICALLY ACCEPTABLE ANAGRELIDE SALT, NON-ORAL PHARMACEUTICAL COMPOSITION, AND MEDICAL DEVICE FOR TRANSDERMAL ADMINISTRATION". The present invention relates to a method for treating or preventing thrombocythemia in a patient comprising non-oral administration to said patient of an effective amount of anagrelide, base anagrelide, or a pharmaceutically salt acceptable for the anagrelide so that the first pass through the liver metabolic process is avoided.